You are here:

rifaximin (Xifaxanta)


In the absence of a submission from the holder of the marketing authorisation:

rifaximin 200 mg film coated tablets (Xifaxanta®) is not recommended for use within NHS Scotland.

Indication under review: treatment of travellers' diarrhoea that is not associated with any of:

  • Fever
  • Bloody diarrhoea
  • Eight or more unformed stools in the previous 24 h
  • Occult blood or leucocytes in the stool.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: rifaximin (Xifaxanta)
SMC Drug ID: 808/12
Manufacturer: Norgine Ltd
Indication: Treatment of travellers' diarrhoea.
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 August 2012